Trialbee and ERGOMED Have Partnered to Recruit Patients for New Rare Disease Innovation Center
rawpixel / Pixabay

Trialbee and ERGOMED Have Partnered to Recruit Patients for New Rare Disease Innovation Center

According to a recent article, Trialbee and ERGOMED have partnered to become the platform for patient recruitment for their new Rare Disease Innovation Center. Trialbee Trialbee is the leading platform…

Continue Reading Trialbee and ERGOMED Have Partnered to Recruit Patients for New Rare Disease Innovation Center

CRISPR Continues to Cut Impressive Numbers in Beta-Thalassemia, Sickle Cell Disease, and More

A year ago, Paddy Doherty’s doctor told him that he had a rare hereditary disease called transthyretin (ATTR) amyloidosis, the same disease that had killed his father. As reported in…

Continue Reading CRISPR Continues to Cut Impressive Numbers in Beta-Thalassemia, Sickle Cell Disease, and More
Webinar: Introducing a New Guide to Patient Focused Rare Disease Drug Development
source: pixabay.com

Webinar: Introducing a New Guide to Patient Focused Rare Disease Drug Development

On January 27, 2022, The EveryLife Foundation for Rare Diseases, in partnership with the Biotechnology Innovation Organization (BIO), National Health Council, and Pharmaceutical Research and Manufacturers of America (PhRMA), hosted…

Continue Reading Webinar: Introducing a New Guide to Patient Focused Rare Disease Drug Development
Successful Transplant of Pig Kidneys to a Human Patient Could Change The Course of Organ Transplantation
Source: Pixabay

Successful Transplant of Pig Kidneys to a Human Patient Could Change The Course of Organ Transplantation

A study recently published in the American Journal of Transplantation evaluated whether or not transplanting the kidney of a pig could be a viable and safe options for human patients. This study…

Continue Reading Successful Transplant of Pig Kidneys to a Human Patient Could Change The Course of Organ Transplantation